Larvol Delta - Caribou-Biosciences-Presents-Case-Report-on-Longterm-Follow-up-of-First-Patient-Dosed-in-Phase-1-ANTLER-Trial-at-the-Lymphoma-Leukemia-amp-Myeloma-Congress-2022

CB-010 - Caribou Biosci

https://www.globenewswire.com/news-release/2022/10/18/2536454/0/en/Caribou-Biosciences-Presents-Case-Report-on-Long-term-Follow-up-of-First-Patient-Dosed-in-Phase-1-ANTLER-Trial-at-the-Lymphoma-Leukemia-Myeloma-Congress-2022.html

Oct 18, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next